S&P 500 7,722.60 +0.60%
Nasdaq 26,477.81 +1.18%
S&P/TSX 36,171.49 +0.63%
Apple 347.10 +0.93%
Nvidia 217.94 +0.90%
Microsoft 531.33 −0.24%
Shopify 232.93 −1.27%
Royal Bank 285.46 +0.42%
CAD/USD 0.7109 −0.38%
CLOSED · 01:40 ET
Market ClerkRecap
Wed Oct 28 · markets closed3 signals on Oct 27171 insider buys this week · $184.9MCIRO short report next: Oct 30The week ahead
VH
INSIDER · LYCA · Lycia Therapeutics, Inc. · 10% OWNER

Venrock Healthcare Capital Partners III, L.P.

Every open-market transaction filed under this name, Oct 23 to Oct 27.

Filings
6
6 buys · 0 sells
Bought
$37.7M
open market, at cost
Sold
—
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 27LYCALycia Therapeutics, Inc.10% ownerBuy31,067$26.84$834K—
Oct 27LYCALycia Therapeutics, Inc.10% ownerBuy8,729$25.84$226K—
Oct 26LYCALycia Therapeutics, Inc.10% ownerBuy8,261$26.97$223K—
Oct 26LYCALycia Therapeutics, Inc.10% ownerBuy1,944,444$18.00$35M—
Oct 23LYCALycia Therapeutics, Inc.10% ownerBuy28,379$26.11$741K—
Oct 23LYCALycia Therapeutics, Inc.10% ownerBuy24,560$25.68$631K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.